News

Jeevan Scientific Technology Ltd share price declined by 2.33% to Rs 78.52 after the company`s net profit witnessed a sharp fall of 52.72% to Rs 0.87 crore, while revenue from operations reduced 14.14% to Rs 18.28 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 39847.85 crore, retreating 13.17%. It has marginally improved by 2.14% over last one week and heading higher by 9.92% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has softened by 2.39% and 5.67% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 0.98 crore in Q2 FY26, plunging by 126.27% year-on-year, and crashing by 61.72% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 231.75% YoY and tanking 30.67% sequentially. Total expenses eased by 8.39% to Rs 17.03 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.71 crore, inching up 5.56% YoY, while employee benefits expense was at Rs 5.74 crore, slipping by 3.85% YoY. For the TTM ended FY26, revenue from operations improved 18.13% to Rs 46.84 crore, while net profit tanked by 104.51% to Rs 0.06 crore, compared to previous TTM. EBITDA soared by 327% to Rs 6.76 crore, and PBT collapsed by 103.13% to Rs 0.05 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd jumped 86.46% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Net profit of Jeevan Scientific Technology reported to Rs 1.61 crore in the quarter ended March 2026 as against net loss of Rs 1.30 crore during the previous quarter ended March 2025. Sales rose 111.63% to Rs 21.29 crore in the quarter ended March 2026 as against Rs 10.06 crore during the previous quarter ended March 2025.For the full year,net profit rose 784.62% to Rs 1.15 crore in the year ended March 2026 as against Rs 0.13 crore during the previous year ended March 2025. Sales rose 31.38% to Rs 61.54 crore in the year ended March 2026 as against Rs 46.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales21.2910.06 112 61.5446.84 31 OPM %20.15-3.88 -15.9215.82 - PBDT4.17-0.78 LP 8.736.30 39 PBT2.56-2.55 LP 2.090.05 4080 NP1.61-1.30 LP 1.150.13 785 Powered by Capital Market - Live News

Jeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Jeevan Scientific Technology rose 1190.91% to Rs 1.42 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 52.44% to Rs 19.07 crore in the quarter ended December 2025 as against Rs 12.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales19.0712.51 52 OPM %27.4316.55 - PBDT4.831.87 158 PBT3.230.39 728 NP1.420.11 1191 Powered by Capital Market - Live News

Jeevan Scientific Tech. has postponed the meeting of the Board of Directors which was scheduled to be held on 30 December 2025. The meeting will now be held on 2 January 2026.Powered by Capital Market - Live News